RXSIGHT INC (RXST) — insider trading
Health Care · NASDAQ
RXSIGHT INC (RXST) has 57 reported SEC Form 4 insider transactions in our data, including 4 open-market sales among the most recent 57 (latest 2026-09-15).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Weinberg Eric | Officer (See remarks) | Option exercise / conversion (derivative) | 35,168 | — | $0 | Form 4 |
| 2026-09-15 | Weinberg Eric | Officer (See remarks) | Option exercise / conversion | 35,168 | $4.34 | $152.6K | Form 4 |
| 2026-09-05 | Wilterding Mark | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 258,770 | — | — | Form 4 |
| 2026-09-05 | Wilterding Mark | Officer (Chief Financial Officer) | Disposition to the issuer (derivative) | 258,770 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Grant / award / vesting (derivative) | 93,984 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Grant / award / vesting (derivative) | 32,258 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Grant / award / vesting (derivative) | 59,483 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Grant / award / vesting (derivative) | 82,608 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Grant / award / vesting (derivative) | 65,742 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Disposition to the issuer (derivative) | 125,000 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Disposition to the issuer (derivative) | 50,000 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Disposition to the issuer (derivative) | 92,200 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Disposition to the issuer (derivative) | 95,000 | — | — | Form 4 |
| 2026-09-05 | Weinberg Eric | Officer (See remarks) | Disposition to the issuer (derivative) | 87,437 | — | — | Form 4 |
| 2026-09-05 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 161,654 | — | — | Form 4 |
| 2026-09-05 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 96,129 | — | — | Form 4 |
| 2026-09-05 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 173,913 | — | — | Form 4 |
| 2026-09-05 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 254,751 | — | — | Form 4 |
| 2026-09-05 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Disposition to the issuer (derivative) | 215,000 | — | — | Form 4 |
| 2026-09-05 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Disposition to the issuer (derivative) | 149,000 | — | — | Form 4 |
| 2026-09-05 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Disposition to the issuer (derivative) | 200,000 | — | — | Form 4 |
| 2026-09-05 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Disposition to the issuer (derivative) | 338,819 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 93,984 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 32,258 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 59,483 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 104,347 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 73,960 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Disposition to the issuer (derivative) | 125,000 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Disposition to the issuer (derivative) | 50,000 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Disposition to the issuer (derivative) | 92,200 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Disposition to the issuer (derivative) | 120,000 | — | — | Form 4 |
| 2026-09-05 | Goldshleger Ilya | Officer (Chief Operating Officer) | Disposition to the issuer (derivative) | 98,367 | — | — | Form 4 |
| 2026-09-02 | Weinberg Eric | Officer (See remarks) | Open-market sale | 2,041 | $6.96 | $14.2K | Form 4 |
| 2026-09-02 | Goldshleger Ilya | Officer (Chief Operating Officer) | Open-market sale | 2,041 | $6.96 | $14.2K | Form 4 |
| 2026-09-02 | Wilterding Mark | Officer (Chief Financial Officer) | Open-market sale | 7,765 | $6.96 | $54.0K | Form 4 |
| 2026-09-02 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Open-market sale | 5,100 | $6.96 | $35.5K | Form 4 |
| 2026-08-31 | Weinberg Eric | Officer (See remarks) | Option exercise / conversion (derivative) | 5,370 | — | $0 | Form 4 |
| 2026-08-31 | Weinberg Eric | Officer (See remarks) | Option exercise / conversion | 5,370 | — | — | Form 4 |
| 2026-08-31 | Goldshleger Ilya | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 5,370 | — | $0 | Form 4 |
| 2026-08-31 | Goldshleger Ilya | Officer (Chief Operating Officer) | Option exercise / conversion | 5,370 | — | — | Form 4 |
| 2026-08-31 | Wilterding Mark | Officer (Chief Financial Officer) | Option exercise / conversion (derivative) | 20,441 | — | $0 | Form 4 |
| 2026-08-31 | Wilterding Mark | Officer (Chief Financial Officer) | Option exercise / conversion | 20,441 | — | — | Form 4 |
| 2026-08-31 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Option exercise / conversion (derivative) | 13,425 | — | $0 | Form 4 |
| 2026-08-31 | Kurtz Ronald M MD | Officer (Chief Medical Officer) | Option exercise / conversion | 13,425 | — | — | Form 4 |
| 2026-07-24 | Mottiwala Aziz | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 571,286 | — | $0 | Form 4 |
| 2026-07-24 | Mottiwala Aziz | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 2,312,138 | — | $0 | Form 4 |
| 2026-06-17 | Andrews Julie | Director | Grant / award / vesting | 37,037 | — | — | Form 4 |
| 2026-06-17 | Tammenoms Bakker Juliet | Director | Grant / award / vesting | 37,037 | — | — | Form 4 |
| 2026-06-17 | COHEN RAYMOND W | Director | Grant / award / vesting | 30,864 | — | — | Form 4 |
| 2026-06-17 | Corley Jesse Anderson | Director | Grant / award / vesting | 37,037 | — | — | Form 4 |
| 2026-06-17 | LINK WILLIAM J PHD | Director | Grant / award / vesting | 37,037 | — | — | Form 4 |
| 2026-06-17 | Fountain Tamara | Director | Grant / award / vesting | 37,037 | — | — | Form 4 |
| 2026-06-17 | Maniar Shweta | Director | Grant / award / vesting | 37,037 | — | — | Form 4 |
| 2026-06-17 | PALMISANO ROBERT J | Director | Grant / award / vesting | 37,037 | — | — | Form 4 |
| 2026-06-17 | Warner Robert Keith | Director | Grant / award / vesting | 37,037 | — | — | Form 4 |
| 2026-04-17 | Goldshleger Ilya | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 12,489 | — | $0 | Form 4 |
| 2026-04-17 | Goldshleger Ilya | Officer (Chief Operating Officer) | Option exercise / conversion | 12,489 | $4.13 | $51.6K | Form 4 |
Ask the chat about RXST's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: RXSIGHT INC (RXST).
Last updated 2026-09-15 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.